$GRHI
GOLD ROCK HOLDINGS, INC.

2024 Q2 Form 10-Q Financial Statement

#000109181824000047 Filed on May 02, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $6.500K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit $6.500K
YoY Change
Gross Profit Margin 100.0%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $99.50K $165.6K $196.4K
YoY Change 866.2% -15.67% 282.4%
Operating Profit -$93.00K -$165.6K -$196.4K
YoY Change 803.08% -15.67% 282.4%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $3.000K $3.000K
YoY Change 0.0% 0.0%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$93.00K -$165.6K -$196.4K
YoY Change 803.08% -15.67% 282.4%
Net Earnings / Revenue -1430.75%
Basic Earnings Per Share $0.00 $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 236.9M shares 231.1M shares 87.48M shares
Diluted Shares Outstanding 238.1M shares 234.8M shares 93.86M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $234.6K $259.2K $1.236K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $5.725K
Receivables $6.500K
Other Receivables
Total Short-Term Assets $241.1K $259.2K $6.961K
YoY Change 20197.47% 3623.42%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $241.1K $259.2K $6.961K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $241.1K $259.2K $6.961K
YoY Change 20197.47% 3623.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $83.82K $83.88K $2.210K
YoY Change 1584.84% 3695.25%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $83.82K $83.88K $2.210K
Total Long-Term Liabilities
Total Liabilities $83.82K $83.88K $2.210K
YoY Change 1584.84% 3695.25%
SHAREHOLDERS EQUITY
Retained Earnings -$1.125M -$1.032M -$830.1K
YoY Change 33.82% 24.28%
Common Stock $238.1K $236.9K $231.1K
YoY Change 3.07% 2.52%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $157.3K $175.3K $4.751K
YoY Change
Total Liabilities & Shareholders Equity $241.1K $259.2K $6.961K
YoY Change 20197.47% 3623.42%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$93.00K -$165.6K -$196.4K
YoY Change 803.08% -15.67% 282.4%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$91.62K -$48.00
YoY Change 190777.08% -99.73%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $350.7K
YoY Change
NET CHANGE
Cash From Operating Activities -$91.62K -$48.00
Cash From Investing Activities
Cash From Financing Activities $350.7K
Net Change In Cash $259.1K -$48.00
YoY Change -539847.92%
FREE CASH FLOW
Cash From Operating Activities -$91.62K -$48.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Revenues
Revenues
usd
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
usd
CY2023Q4 grhi Accrued Board Of Director Compensation
AccruedBoardOfDirectorCompensation
usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
4751 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-9792 usd
CY2023Q1 us-gaap Revenues
Revenues
usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
usd
CY2024Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
usd
CY2023Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
usd
CY2024Q1 grhi Common Stock Issued For Board Of Director And Consulting Services
CommonStockIssuedForBoardOfDirectorAndConsultingServices
usd
CY2024Q1 grhi Common Stock Issued To Prepay Director For Payment Of Operating Expenses
CommonStockIssuedToPrepayDirectorForPaymentOfOperatingExpenses
usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
CY2023Q1 grhi Increase Decrease In Accrued Board Of Directors Compensation
IncreaseDecreaseInAccruedBoardOfDirectorsCompensation
usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2023Q1 us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2024Q1 us-gaap Interest Paid
InterestPaid
usd
CY2023Q1 us-gaap Interest Paid
InterestPaid
usd
CY2024Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
236886969 shares
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
259187 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
259187 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
108 usd
CY2024Q1 us-gaap Assets
Assets
259187 usd
CY2023Q4 us-gaap Assets
Assets
108 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3875 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
9900 usd
CY2024Q1 grhi Accrued Board Of Director Compensation
AccruedBoardOfDirectorCompensation
80000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
83875 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
9900 usd
CY2024Q1 us-gaap Liabilities
Liabilities
83875 usd
CY2023Q4 us-gaap Liabilities
Liabilities
9900 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
850000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
850000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
236886969 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
236886969 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
231053636 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
231053636 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
236886 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
231053 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
970059 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
625192 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1031633 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-866037 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
175312 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-9792 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
259187 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
108 usd
CY2024Q1 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
100000 usd
CY2023Q1 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
170000 usd
CY2024Q1 grhi Consulting Fees Expenses
ConsultingFeesExpenses
10500 usd
CY2023Q1 grhi Consulting Fees Expenses
ConsultingFeesExpenses
3000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
55096 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23358 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
165596 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
196358 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-165596 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-196358 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
234808214 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
234808214 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
93863160 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
93863160 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q1 grhi Common Stock Issued For Board Of Director And Consulting Services
CommonStockIssuedForBoardOfDirectorAndConsultingServices
172000 usd
CY2023Q1 grhi Common Stock Issued To Prepay Director For Payment Of Operating Expenses
CommonStockIssuedToPrepayDirectorForPaymentOfOperatingExpenses
29000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
5725 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-6025 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1035 usd
CY2024Q1 grhi Increase Decrease In Accrued Board Of Directors Compensation
IncreaseDecreaseInAccruedBoardOfDirectorsCompensation
-80000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-91621 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-48 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
350000 usd
CY2024Q1 us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
700 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
350700 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
259079 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-48 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
108 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1284 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
259187 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1236 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-401891 usd
CY2023Q1 grhi Common Stock Issued For Accounts Payable And Accrued Expenses
CommonStockIssuedForAccountsPayableAndAccruedExpenses
402000 usd
CY2023Q1 grhi Common Stock Issued To Prepay Director For Payment Of Operating Expense
CommonStockIssuedToPrepayDirectorForPaymentOfOperatingExpense
29000 usd
CY2023Q1 grhi Common Stock Issued For Board Of Director Consulting Services
CommonStockIssuedForBoardOfDirectorConsultingServices
172000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-196358 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
350000 usd
CY2024Q1 grhi Capital Contributions Director
CapitalContributionsDirector
700 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-165596 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
175312 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_844_eus-gaap--UseOfEstimates_zGzs7kKJlev9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86A_zK73C7BON4w9">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of condensed consolidated financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1031633 usd
CY2024Q1 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
700 usd
CY2023Q1 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
23275 usd
CY2024Q1 grhi Common Stock Issued To Prepay Director For Payments Of Operating Expenses
CommonStockIssuedToPrepayDirectorForPaymentsOfOperatingExpenses
29000 usd
CY2024Q1 grhi Stock Issuance To Reimburse
StockIssuanceToReimburse
0.0042
CY2024Q1 grhi Agreement Monthly Charges
AgreementMonthlyCharges
1000 usd
CY2024Q1 us-gaap Other Expenses
OtherExpenses
3000 usd
CY2023Q1 us-gaap Other Expenses
OtherExpenses
3000 usd
CY2024Q1 grhi Accounts Payable
AccountsPayable
2000 usd
CY2023Q1 grhi Accounts Payable
AccountsPayable
1000 usd
CY2028Q4 grhi Agreement Amount Payable
AgreementAmountPayable
95000 usd
CY2023Q1 grhi Agreement Amount Payable
AgreementAmountPayable
75000 usd
CY2023Q1 grhi Board Of Director Compensation
BoardOfDirectorCompensation
170000 usd
CY2024Q1 us-gaap Related Party Transaction Description Of Transaction
RelatedPartyTransactionDescriptionOfTransaction
The Company entered into an agreement with the officer of Loot8 for $12,500 monthly of which $10,000 will be monthly and $2,500 will be deferred until the Company’s financial health is projected to support full payment.
CY2024Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
100000 usd
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
850000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
850000000 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
236886969 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
236886969 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
231053636 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
231053636 shares
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
40952381 usd
CY2023Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
172000 shares
CY2023Q1 grhi Common Stock Issued For Consulting And Director Compensation Shares
CommonStockIssuedForConsultingAndDirectorCompensationShares
6904761 shares
CY2023Q1 grhi Common Stock Issued For Consulting And Director Compensation
CommonStockIssuedForConsultingAndDirectorCompensation
29000 usd
CY2024Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
5833333 shares
CY2024Q1 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
350000 usd
CY2024Q1 grhi Sponsorship Description
SponsorshipDescription
Company’s wholly owned subsidiary entered into a sponsorship commitment with the University of Houston in the amount of $125,000 for one year ending on February 12, 2025, to be paid in twelve (12) installments of $10,416.66 each.
CY2024Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
20827 usd
CY2024Q1 grhi Due To Related Party
DueToRelatedParty
104173 usd

Files In Submission

Name View Source Status
0001091818-24-000047-index-headers.html Edgar Link pending
0001091818-24-000047-index.html Edgar Link pending
0001091818-24-000047.txt Edgar Link pending
0001091818-24-000047-xbrl.zip Edgar Link pending
ex1001.htm Edgar Link pending
ex1001001.jpg Edgar Link pending
ex1002.htm Edgar Link pending
ex1003.htm Edgar Link pending
ex1003001.jpg Edgar Link pending
ex311.htm Edgar Link pending
ex312.htm Edgar Link pending
ex321.htm Edgar Link pending
ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
grhi-20240331.xsd Edgar Link pending
grhi20240331.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
grhi-20240331_cal.xml Edgar Link unprocessable
grhi-20240331_def.xml Edgar Link unprocessable
grhi-20240331_lab.xml Edgar Link unprocessable
grhi-20240331_pre.xml Edgar Link unprocessable
grhi20240331_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable